دورية أكاديمية
أعرض في EDS

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study

التفاصيل البيبلوغرافية
العنوان: Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
المؤلفون: Tanuja Chitnis, Angelo Ghezzi, Kumaran Deiva, Peter Huppke, Brenda Banwell, Lauren Krupp, Emmanuelle Waubant, Jutta Gaertner, Virginia DeLasHeras, Amin Azmon, Rajesh Karan
المصدر: BMJ Neurology Open, Vol 4, Iss 1 (2022)
بيانات النشر: BMJ Publishing Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
مصطلحات موضوعية: Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
الوصف: Background In the PARADIGMS Study, fingolimod demonstrated superior efficacy versus interferon (IFN) β-1a and comparable overall incidence of adverse events but slightly higher rate of serious adverse events in patients with paediatric-onset multiple sclerosis (PoMS). Here, we report the health-related quality of life (HRQoL) outcomes from PARADIGMS.Methods Patients with PoMS (N=215; aged 10–
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2632-6140
Relation: https://neurologyopen.bmj.com/content/4/1/e000215.full; https://doaj.org/toc/2632-6140
DOI: 10.1136/bmjno-2021-000215
URL الوصول: https://doaj.org/article/860df43c8cbd41c3b813a5753b7ea96d
رقم الأكسشن: edsdoj.860df43c8cbd41c3b813a5753b7ea96d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:26326140
DOI:10.1136/bmjno-2021-000215